Medical requirement needed for ongoing studies with the cdmrp terp project involving plethysmography in mice. The current equipment is at/past IT's life expectancy.
Ended Awarded Last action
- Contract number
- HT009025FG0310010
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $59,544
Award facts
- Contract value 100% obligated
- $59,544.09 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a $59,544.09 firm fixed-price blanket purchase agreement (BPA) call order to Harvard Bioscience Inc., operating as Data Sciences International, on March 5, 2025. This task order supports ongoing studies under the Congressionally Directed Medical Research Programs Teprotide (CDMRP TERP) project, which requires replacement of plethysmography equipment for mice that has reached or exceeded its operational life expectancy. The work will be performed at the awardee's facility in Mounds View, Minnesota, with completion targeted for September 30, 2025. No set-aside designation was applied to this procurement.
This call order is issued under Harvard Bioscience's existing $4.8 million single-award BPA with the Defense Health Agency, which was awarded in May 2022 and runs through May 3, 2027. The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency, Army Medical Command, and other military health system partners to procure specialized biomedical research equipment and services, including telemetry systems, physiological monitoring devices, surgical services, and data acquisition software. To date, task orders under this BPA have generated over $1.5 million in cumulative procurement value, reflecting its strategic importance to defense and military health sector research initiatives.
Quick answers
Who was awarded contract HT009025FG0310010?
HT009025FG0310010 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on March 5, 2025.
How much is contract HT009025FG0310010 worth?
The government has obligated $59,544 on HT009025FG0310010.
Is contract HT009025FG0310010 an order under another contract?
Yes. HT009025FG0310010 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT009025FG0310010 competed?
The government received 3 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award